open access

Vol 85, No 6 (2014)
ARTICLES
Get Citation

Carcinoma of the cervical stump – multicenter study

Tomasz Rechberger, Katarzyna Perżyło, Paweł Miotła, Ewa Nowak-Markwitz, Mikołaj Zaborowski, Agnieszka Lemańska, Włodzimierz Baranowski, Andrzej Nowakowski, Małgorzata Reinholz-Jaskólska, Włodzimierz Sawicki
DOI: 10.17772/gp/1749
·
Ginekol Pol 2014;85(6).

open access

Vol 85, No 6 (2014)
ARTICLES

Abstract

Objectives: Cervix-sparing hysterectomy due to benign conditions remains controversial, especially when the presumed risk of cervical cancer in the retained cervical stump is concerned. On the other hand, supracervical hysterectomy is associated with shorter operative time, decreased blood loss and decreased intraoperative complications. Moreover, beneficial effects of retaining the cervix on the pelvic statics and female psychosexual functioning have been suggested, although not yet proven. The aim: The aim of the study was to determine the frequency and types of cervical cancers in the retained cervical stump after supracervical hysterectomy performed due to benign diseases of the uterine corpus in four academic settings. Material and methods: Retrospective review of medical records of 903 women who underwent treatment due to cervical carcinoma in four departments participating in the study: Centre 1- 2nd Department of Gynecology, Medical University, Lublin (years: 2001- 2011); Centre 2- Department of Gynecology and Gynecologic Oncology, Military Institute of Medicine, Warsaw (years: 2002-2012); Centre 3- Katedra i Kliniki Położnictwa, Chorób Kobiecych i Ginekologii Onkologicznej II Wydziału Lekarskiego WUM, Warsaw (years: 2008-2013) and Centre 4- Department of Gynecologic Oncology, Poznań University of Medical Sciences, (years: 2000-2012). The occurrence rate of cervical stump carcinoma was reported in relation to patient age, time elapsed between supracervical hysterectomy and diagnosis stump cancer, and histological type of cancer. Results: Only 3 cases of cervical stump carcinoma (0.33%) were identified among the 903 investigated women. In all these cases, cervical stump cancers were diagnosed several years after supracervical hysterectomy. In one case the only treatment was radiotherapy, in one case only trachelectomy was performed, whereas in one case surgery followed by radiotherapy was used. Conclusions: It should be remembered that subtotal hysterectomy carries a risk, albeit relatively low, of developing stump cancer. Therefore, patients should be informed that after such operation further cervical cancer screening is mandatory. Moreover, subtotal hysterectomy should not be offered in populations at risk of developing cancer of the uterine cervix.

Abstract

Objectives: Cervix-sparing hysterectomy due to benign conditions remains controversial, especially when the presumed risk of cervical cancer in the retained cervical stump is concerned. On the other hand, supracervical hysterectomy is associated with shorter operative time, decreased blood loss and decreased intraoperative complications. Moreover, beneficial effects of retaining the cervix on the pelvic statics and female psychosexual functioning have been suggested, although not yet proven. The aim: The aim of the study was to determine the frequency and types of cervical cancers in the retained cervical stump after supracervical hysterectomy performed due to benign diseases of the uterine corpus in four academic settings. Material and methods: Retrospective review of medical records of 903 women who underwent treatment due to cervical carcinoma in four departments participating in the study: Centre 1- 2nd Department of Gynecology, Medical University, Lublin (years: 2001- 2011); Centre 2- Department of Gynecology and Gynecologic Oncology, Military Institute of Medicine, Warsaw (years: 2002-2012); Centre 3- Katedra i Kliniki Położnictwa, Chorób Kobiecych i Ginekologii Onkologicznej II Wydziału Lekarskiego WUM, Warsaw (years: 2008-2013) and Centre 4- Department of Gynecologic Oncology, Poznań University of Medical Sciences, (years: 2000-2012). The occurrence rate of cervical stump carcinoma was reported in relation to patient age, time elapsed between supracervical hysterectomy and diagnosis stump cancer, and histological type of cancer. Results: Only 3 cases of cervical stump carcinoma (0.33%) were identified among the 903 investigated women. In all these cases, cervical stump cancers were diagnosed several years after supracervical hysterectomy. In one case the only treatment was radiotherapy, in one case only trachelectomy was performed, whereas in one case surgery followed by radiotherapy was used. Conclusions: It should be remembered that subtotal hysterectomy carries a risk, albeit relatively low, of developing stump cancer. Therefore, patients should be informed that after such operation further cervical cancer screening is mandatory. Moreover, subtotal hysterectomy should not be offered in populations at risk of developing cancer of the uterine cervix.
Get Citation

Keywords

cervical cancer, supracervical hysterectomy, epidemiological study, multicenter study

About this article
Title

Carcinoma of the cervical stump – multicenter study

Journal

Ginekologia Polska

Issue

Vol 85, No 6 (2014)

DOI

10.17772/gp/1749

Bibliographic record

Ginekol Pol 2014;85(6).

Keywords

cervical cancer
supracervical hysterectomy
epidemiological study
multicenter study

Authors

Tomasz Rechberger
Katarzyna Perżyło
Paweł Miotła
Ewa Nowak-Markwitz
Mikołaj Zaborowski
Agnieszka Lemańska
Włodzimierz Baranowski
Andrzej Nowakowski
Małgorzata Reinholz-Jaskólska
Włodzimierz Sawicki

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl